Naveris

Series-A Acquired by CareDx
naveris.com Biotech & Healthcare
Total Funding $33.4M
Latest Round $33.4M Series-A
Last Announced Sep 19, 2022
Investors Undisclosed
Decision Makers Profile Active

About Naveris

Naveris develops highly sensitive blood tests that identify viral cancers significantly earlier than scans or traditional biopsies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Corporate Status Acquired by CareDx
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website naveris.com
Domain Registered Date Aug 30, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $33,400,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    naveris.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Naveris.

Funding History

1 Round
Series-A · Sep 19, 2022

Founders & Leadership

1

Piyush Gupta

Executive Chairman, Founder, & Chief Science & Technology Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts